Efficacy of proveblue (methylene blue) in an experimental cerebral malaria murine model

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 7, 2013, Pages 3412-3414

  Dormoi, Jérome ^a,b   Briolant, Sébastien ^a,b,c,d   Desgrouas, Camille ^a   Pradines, Bruno ^a,b  

^a INSTITUT DE RECHERCHE BIOMÉDICALE DES ARMÉES   (France)

^b AIX MARSEILLE UNIVERSITÉ   (France)

^c Direction Inter Armées du Service de Santé   (French Guiana)

^d INSTITUT PASTEUR DE LA GUYANE   (French Guiana)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROARTEMISININ; METHYLENE BLUE; PROVEBLUE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMICROBIAL THERAPY; ARTICLE; BRAIN MALARIA; CONTROLLED STUDY; DEATH; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG RESPONSE; FEMALE; IN VIVO STUDY; MONOTHERAPY; MOUSE; NONHUMAN; PARASITEMIA; PLASMODIUM BERGHEI INFECTION; PRIORITY JOURNAL; SURVIVAL RATE;

ANIMALS; ANTIMALARIALS; ARTEMISININS; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; FEMALE; MALARIA, CEREBRAL; METHYLENE BLUE; MICE; MICE, INBRED C57BL; PLASMODIUM BERGHEI;

EID: 84879028216     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02381-12     Document Type: Article

References (20)

1. Dondorp A, Nosten F, Stepniewska K, Day N, White N, South-East Asian Quinine Artesunate Malaria Trial (SEAQUAMAT) Group. 2005. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet 366:717-735.
2. Dondorp AM, Fanello CI, Hendriksen ICE, Gomes E, Seni A, Chhaganlal KD, Bojang K, Olaosebikan R, Anunobi N, Maitland K, Kivaya E, Agbenyega T, Blay Nguah S, Evans J, Gesase S, Kahabuka C, Mtove G, Nadjm B, Deen J, Mwanga-Amumpaire J, Nansumba M, Karema C, Umulisa N, Uwimana A, Mokuolu OA, Adedoyin OT, Jonhson WBR, Tshefu AK, Onyamboko MA, Sakulthaew T, Pan Ngum W, Silamut K, Stepniewska K, Woodrow CJ, Bethell D, Wills B, Oneko M, Peto TE, von Seidlein L, Day NPJ, White NJ, AQUAMAT group. 2010. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet 376: 1647-1657.
3. Amaratunga C, Sreng S, Suon S, Phelps ES, Stepniewska K, Lim P, Zhou C, Mao S, Anderson JM, Lindegardh N, Jiang H, Song J, Su XZ, White NJ, Dondorp AM, Anderson TCJ, Fay MP, Mu J, Duong S, Fairhurst RM. 2012. Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study. Lancet Infect. Dis. 12:851-858.
4. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwrong M, Chotivanish K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NPJ, Lindegardh N, Socheat D, White NJ. 2009. Artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 361:455-467.
5. Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM. 2008. Evidence of artemisinin-resistant malaria in western Cambodia. N. Engl. J. Med. 359:2619-2620.
6. White NJ. 1998. Preventing antimalarial drug resistance through combinations. Drug Resist. Updat. 1:3-9.
7. Pascual A, Henry M, Briolant S, Charras S, Baret E, Amalvict R, Huyghues des Etages E, Feraud M, Rogier C, Pradines B. 2011. In vitro activity of Proveblue (methylene blue) on Plasmodium falciparum strains resistant to standard antimalarial drugs. Antimicrob. Agents Chemother. 55:2472-2474.
8. Dormoi J, Pascual A, Briolant S, Amalvict R, Charras S, Baret E, Huyghues des Etages E, Feraud M, Pradines B. 2012. Proveblue (methylene blue) as antimalarial agent: in vitro synergy with dihydroartemisinin and atorvastatin. Antimicrob. Agents Chemother. 56:3467-3469.
9. Delahaye NF, Coltel N, Puthier D, Barbier M, Benech P, Joly F, Iraqi FA, Grau GE, Nguyen C, Rihet P. 2007. Gene expression analysis reveals early changes in several molecular pathways in cerebral malariasusceptible mice versus cerebral malaria-resistant mice. BMC Genomics 8:452.
10. Lou J, Lucas R, Grau GE. 2001. Pathogenesis of cerebral malaria: recent experimental data and possible applications for humans. Clin. Microbiol. Rev. 14:810-820. (Pubitemid 32979632)
11. White NJ, Turner GD, Medana IM, Dondorp AM, Day NP. 2010. The murine cerebral malaria phenomenon. Trends Parasitol. 26:11-15.
12. Lackner P, Beer R, Heussler V, Goebel G, Rudzki D, Helbok R, Tannich E, Schmutzhard E. 2006. Behavioural and histopathological alterations in mice with cerebral malaria. Neuropathol. Appl. Neurobiol. 32:177-188.
13. Waknine-Grinberg JH, Hunt N, Bentura-Marciano A, McQuillian JA, Chan HW, Chan WC, Barenholtz Y, Haynes RK, Golenser J. 2010. Artemisone effective against murine cerebral malaria. Malar. J. 9:227.
14. Guo J, Guigemde AW, Bentura-Marciano A, Clark K, Haynes RK, Chan WC, Wong HN, Hunt NH, Guy RK, Golenser J. 2012. Synthesis of artemiside and its effects in combination with conventional drugs against severe murine malaria. Antimicrob. Agents Chemother. 56:163-173.
15. Coulibaly B, Zoungrana A, Mockenhaupt FP, Schirmer RH, Klose C, Mansmann U, Meissner P, Müller O. 2009. Strong gametocytocidal effect of methylene blue-based combination therapy against falciparum malaria: a randomized controlled trial. PLos One 4:5318.
16. Meissner PE, Mandi G, Coulibaly B, Witte S, Tapsoba T, Mansmann U, Rengelshausen J, Schiek W, Jahn A, Walter-Sack I, Mikus G, Burhenne J, Riedel KD, Schirmer RH, Kouyaté B, Müller O. 2006. Methylene blue for malaria in Africa: results from a dose-finding study in combination with chloroquine. Malar. J. 5:84.
17. Haynes RK, Cheu KW, Li KY, Tang MMK, Wong HN, Chen MJ, Guo ZF, Guo ZH, Coghi P, Monti D. 2011. A partial convergence in action of methylene blue and artemisinins: antagonism with chloroquine, a reversal with verapamil, and an insight into the antimalarial activity of chloroquine. Chem Med Chem 6:1603-1615.
18. Adjalley SH, Johnston GL, Li T, Eastman RT, Ekland EH, Eappen AG, Richman A, Kim Lee Sim B, Lee MCS, Hoffman SL, Fidock DA. 2011. Quantitative assessment of Plasmodium falciparum sexual development reveals potent transmission- blocking activity by methylene blue. Proc. Natl. Acad. Sci. U. S. A. 108:1214-1223.
19. Lelièvre J, Almeda MJ, Lozano S, Miguel C, Franco, Leroy VD, Herreros E. 2012. Activity of clinical relevant antimalarial drugs on Plasmodium falciparum mature gametocytes in an ATP bioluminescence transmission blocking assay. PLoS One 7:35019.
20. Anthony MP, Burrows JN, Duparc S, Moehrle J, Wells TNC. 2012. The global pipeline of new medicines for the control and elimination of malaria. Malar. J. 11:316.